Doppler tissue imaging unmasks right ventricular function abnormalities in HIV-infected patients

Cardiology Journal

Volumn 17, Issue 6, 2010, Pages 587-593

  Karavidas, Apostolos ^a   Tsiachris, Dimitris ^b   Lazaros, George ^b   Xylomenos, George ^a   Arapi, Sophia ^a   Potamitis, Nikolaos ^a   Matzaraki, Vassiliki ^a   Caplanis, John ^a   Matsakas, Evangelos ^a   Gargalianos, Panos ^a   Pyrgakis, Vlassis ^a   Stefanadis, Christodoulos ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Doppler tissue imaging; HIV; Right ventricular function

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ARTERY PRESSURE; MALE; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; GREECE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TIME FACTORS; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 78951479115     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med, 1998; 339: 1093-1099.
2. Barbaro G, Fisher SD, Lipshultz SE. Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis, 2001; 1: 115-124.
3. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation, 2002; 106: 1420-1425.
4. Jacob AJ, Sutherland GR, Bird AG et al. Myocardial dysfunction in patients infected with HIV: Prevalence and risk factors Br Heart J, 1992; 68: 549-553.
5. Herskowitz A, Wu TC, Willoughby SB et al. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol, 1994; 24: 1025-1032.
6. Casalino E, Laissy JP, Soyer P, Bouvet E, Vachon F. Assessment of right ventricle function and pulmonary artery circulation by Cine MRI in patients with AIDS. Chest, 1996; 110; 1243-1247.
7. Currie P, Jacob A, Foreman A, Elton R, Brettle R, Boon N. Heart muscle disease related to HIV infection: prognostic implications. BMJ, 1994; 309: 1605-1607.
8. d'Arminio Monforte A, Sabin CA, Phillips A et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med, 2005; 165: 416-423.
9. Lebech AN, Gerstoft J, Hesse B, Peterse CL, Kjaer A. Right and left ventricular cardiac function in a eveloped world population with human immunodeficiency virus studied with radionuclide ventriculography. Am Heart J, 2004; 147: 482-488.
10. Martinez-Garcia T, Sobrino JM, Pujol E, Galvez J, Benitez E, Giron-Gonzalez JA. Ventricular mass and diastolic function in patients infected by the human immunodeficiency virus. Heart, 2000; 84: 620-624.
11. Karavidas A, Foukarakis M, Lazaros G et al. Assessment of cardiac function with Doppler tissue imaging in asymptomatic HIV-infected patients. Int J STD AIDS, 2008; 19: 227-231.
12. Schuster I, Thöni GJ, Edérhy S et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol, 2008; 101: 1213-1217.
13. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep, 1992; 41 (RR-17): 1-19.
14. Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens, 2009; 27: 2121-2158.
15. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification. Eur J Echocardiography, 2006; 7: 79-108.
16. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol, 1986; 57: 450-445.
17. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation, 1991; 84: 1280-1287.
18. Donovan CL, Armstrong WF, Bach DS. Quantitative Doppler tissue imaging of the left ventricular myocardium: Validation in normal subjects. Am Heart J, 1995; 130: 100-104.
19. Foale R, Nihoyannopoulos P, McKenna W et al. Echocardiographic measurement of the normal adult right ventricle. Br Heart J, 1986; 56: 33-44.
20. Mittal CM, Wig N, Mishra S, Arora P, Pandey RM. Cardiac dysfunction in human immunodeficiency virus (HIV) infected patients in India. Int J Cardiol, 2006; 107: 136-137.
21. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect, 2000; 40: 282-284.
22. Goundray N, de Zuttere D, Force G et al. Left ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: An echocardiographic study. Eur Heart J, 1995; 16: 61-67.
23. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension: Two new cases and a review of 86 reported cases. Mayo Clin Proc, 1998; 73: 37-45.
24. Kjaer A, Lebech AM, Gerstoft J, Hesse B, Petersen CL. Right ventricular volume and mass determined by cine magnetic resonance imaging in HIV patients with possible right ventricular dysfunction. Angiology, 2006; 57: 341-346.
25. Nikitin N, Witte K. Application of tissue Doppler imaging in cardiology. Cardiology, 2004; 101: 170-814.
26. Currie PF, Boon NA. Immunopathogenesis of HIV-related heart muscle disease: Current perspectives. AIDS, 2003; 17 (suppl. 1): S21-S28.
27. Frerichs FC, Dingemans KP, Brinkman K. Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors. N Engl J Med, 2002; 347: 1895-1896.
28. Meng Q, Lima JA, Lai H et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr, 2002; 30: 306-310.